US Appeals Court Upholds $25M Roundup Verdict Against Bayer

US Appeals Court Upholds $25M Roundup Verdict Against Bayer

A federal appeals court on Friday upheld a $25 million judgment and trial verdict finding Bayer’s Roundup caused a California resident’s non-Hodgkin lymphoma, dealing a blow to the chemical company’s hopes of limiting its legal risk over the weed-killer.

The trial judge did not misapply the law when he allowed the lawsuit by Edwin Hardeman to go to trial, as Bayer has argued, according to a 3-judge panel of the 9th U.S. Circuit Court of Appeals in San Francisco.

A jury in 2019 awarded Hardeman $5 million in compensatory damages and $75 million in punitive damages. The punitive award was later cut to $20 million, and the appeals court also upheld the reduction.

The Hardeman case was the first so-called bellwether trial for federal cases alleging Roundup causes cancer.

Bayer has said that decades of studies have shown Roundup and other glyphosate-based herbicides that dominate the market are safe for human use.

Bayer has committed $9.6 billion to settle 125,000 claims over Roundup and next week will seek preliminary approval for a $2 billion proposed deal to resolve future claims by consumers who have been exposed to Roundup but have not yet gotten sick.

© 2021 Thomson/Reuters. All rights reserved.

Blogs

What Is Black Fungus?

What Is Black Fungus?

Cases of the infection, known by doctors as mucormycosis, are mounting rapidly in coronavirus patients

Water Parks In Demand

Water Parks In Demand

Summer vacation survey shows what moms want to do–and not to do–kids want swimming and water parks